We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

PetVivo Holdings Inc (PETV) USD0.001

Sell:$1.51 Buy:$1.59 Change: No change
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$1.51
Buy:$1.59
Change: No change
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$1.51
Buy:$1.59
Change: No change
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

PetVivo Holdings, Inc. is a development-stage company. The Company is a biomedical device company focused on licensing and commercialization of medical devices and therapeutics for pets. The Company's operating subsidiary, PetVivo, Inc., (PetVivo) is engaged in the business of acquiring/in-licensing and adapting human biomedical technology and products for commercial sale in the veterinary market to treat pets and other animals suffering from arthritis and other painful affliction. As of March 31, 2015, PetVivo's pipeline included 17 therapeutic devices for both veterinary and human clinical applications. PetVivo's pipeline includes VD-01, VD-02 and VD-06, which are indicated for osteoarthritis, and VD-04, which is indicated for urinary incontinence, among others. Its subsidiary also includes Gel-Del Technologies, Inc., which has completed a pivotal clinical trial using their thermoplastic biomaterial as a dermal filler for human cosmetic applications.

Contact details

Address:
5251 Edina Industrial Blvd
EDINA
55439-2910
United States
Telephone:
+1 (952) 2174952
Website:
https://petvivo.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
PETV
ISIN:
US7168174081
Market cap:
$15.93 million
Shares in issue:
9.78 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Gregory Cash
    Chairman of the Board
  • John Lai
    President, Chief Executive Officer, Director
  • Robert Folkes
    Chief Financial Officer
  • Randall Meyer
    Chief Operating Officer, Director
  • Randy Wenthold
    Chief Science Officer
  • John Dolan
    General Counsel, Secretary, Director, Chief Business Development
  • David Masters
    Director of Science and Technology

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.